Scynexis (SCYX) Long-Term Investments (2016 - 2026)
Scynexis (SCYX) posted Long-Term Investments of $13.2 million for Q1 2026, down 19.04% on a QoQ basis from $16.2 million in Q4 2025, and little changed year-over-year from $13.2 million in Q1 2025.
Scynexis (SCYX) Long-Term Investments (2016 - 2026) Analysis & Trends
Scynexis' Long-Term Investments history runs 5 years deep, the most recent figure standing at $13.2 million for Q1 2026.
- Quarterly Long-Term Investments changed 0.02% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (changed 0.02% YoY) and the FY2025 annual result came in at $16.2 million, up 2.53% from the prior year.
- Long-Term Investments was $13.2 million for Q1 2026 at Scynexis, down from $16.2 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $23.6 million in Q4 2023 and bottomed at $1.7 million in Q2 2025.
- A 4-year average of $13.4 million and a median of $13.9 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments soared 68.2% — and 2025, when it slumped 83.71%.
- Scynexis' Long-Term Investments stood at $23.6 million in 2023, then sank by 32.84% to $15.8 million in 2024, then advanced by 2.53% to $16.2 million in 2025, then fell by 19.04% to $13.2 million in 2026.
- Business Quant data shows SCYX's Long-Term Investments at $13.2 million in Q1 2026, $16.2 million in Q4 2025, and $1.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 13.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.15 Mn |
| Dec 31, 2025 | 16.25 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 16.12 Mn |
| Jun 30, 2024 | 10.66 Mn |
| Mar 31, 2024 | 13.94 Mn |
| Dec 31, 2023 | 23.59 Mn |
| Sep 30, 2023 | 17.12 Mn |
| Jun 30, 2023 | 6.34 Mn |
| Sep 30, 2016 | 6.03 Mn |